Chemicals & Advanced Materials Global On demand · 24-48h

Global Hydrolyzed Yeast Extract Market Strategic Research Report

Global Hydrolyzed Yeast Extract Market Strategic Research Re…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Hydrolyzed Yeast Extract Market
$1.18B2025
5.4%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Degree of Protein Hydrolysis: <20%, Moderately Hydrolyzed: 20%–50%, Extensively Hydrolyzed: ≥50%–80%

By Application: Personal Care Products, Cosmetic, Other

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Angel Yeast(CN), Sinochem Nanjing(CN), Tangshan Top Bio_Technology(CN), Ichimaru Pharcos(JP), Thermo Fisher Scientific(US), MP Biomedicals(US), FUJIFILM Irvine Scientific(US), Organotechnie(FR), Solabia Group (FR), Ohly GmbH (DE), Lallemand Animal Nutrition (CA), Leiber GmbH (DE), Biorigin (BR), The Lubrizol Corporation(US), Croda International(GB), BASF(DE), Barnet Products LLC (US), Naturalis Srl (IT), Carrubba Incorporated (US), Ashland (US), Sensient Technologies Corporation (US), Biogründl, S.L. (ES), BOC Sciences (US), Cobiosa (ES), Biocogent LLC (US)

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 150 pages
Market size 2025
$1.18B
Billion USD
Forecast CAGR
5.4%
2025-2032
Forecast 2032
$1.7B
Projected
Regiões
5
Asia Pacific · Latin America · MEA · Europe · North America

Visão geral

Scope of the Report

The global Hydrolyzed Yeast Extract market size is predicted to grow from US$ 1,177 million in 2025 to US$ 1,697 million in 2032; it is expected to grow at a CAGR of 5.4% from 2026 to 2032.

Hydrolyzed yeast extract refers to a mixture of natural active ingredients obtained by using yeast cells (such as Saccharomyces cerevisiae) as raw materials. The cell walls are broken down and intracellular components are released through enzymatic hydrolysis or autolysis. The extract is then separated, concentrated, and dried. It is mainly rich in amino acids, small peptides, nucleotides (such as flavor nucleotides), B vitamins, and minerals. It has excellent nutritional supplementation, flavor enhancement, and bioactivity regulation functions, and is widely used in food flavoring, functional foods, fermentation industries, and cosmetics.

The hydrolyzed yeast extract industry chain consists of upstream raw materials and fermentation systems (carbon sources such as molasses and starch sugars, and yeast cultivation and fermentation), midstream processing (yeast autolysis/enzymatic hydrolysis, hydrolysis and cell wall breaking, separation and purification, and spray drying to form powder or paste products), and downstream applications (food flavorings such as flavor enhancers and MSG substitutes, functional foods, animal nutrition, and cosmetic raw materials). Upstream fermentation raw materials account for a relatively high cost but have limited added value, with gross profit margins typically ranging from 10% to 25%. Midstream hydrolysis and extraction processing has certain technological and formulation barriers (such as nucleotide control and flavor-oriented development), with gross profit margins generally ranging from 25% to 50%. Downstream brands and applications, relying on formulation and channel advantages, can achieve gross profit margins of 40% to 70%. Overall, the industry structure presents a pattern of "fermentation raw material-driven growth + midstream process value-added growth + downstream application premium."

In 2025, the average price of hydrolyzed yeast extract was US$5,000/ton, with sales volume of 240.6 k tons and a production capacity of 344 k tons.

Hydrolyzed yeast extract is gradually evolving from a traditional "natural flavor enhancer" into a complex bio-based raw material with both nutritional and functional properties. Its core value lies in its rich content of small molecule peptides, flavor nucleotides, and B vitamins. It can not only replace MSG to meet "clean label" requirements but also provide immune regulation and gut health support in functional foods and animal nutrition. From an industry perspective, its growth is primarily driven by the trend of reducing salt and additives in the food industry, the demand for natural alternatives, and advancements in fermentation biotechnology. However, it also faces challenges such as relatively high costs, increasing demands for customized flavors, and intensified competition from hydrolyzed plant proteins. Future industry development will increasingly rely on precise fermentation control and targeted enzymatic hydrolysis technology to achieve flavor differentiation and functional segmentation, thereby driving the transformation of hydrolyzed yeast extract from a "basic ingredient" to a "high-value-added functional raw material."

Key Questions Addressed in this Report

What is the 10-year outlook for the global Hydrolyzed Yeast Extract market?

What factors are driving Hydrolyzed Yeast Extract market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Hydrolyzed Yeast Extract market opportunities vary by end market size?

How does Hydrolyzed Yeast Extract break out by Type, by Application?

This report presents a comprehensive overview of the global Hydrolyzed Yeast Extract market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Degree of Protein Hydrolysis: <20%
  • Moderately Hydrolyzed: 20%–50%
  • Extensively Hydrolyzed: ≥50%–80%

Segment by Molecular Weight Distribution

  • Large Molecule Peptides
  • Medium Molecule Peptides
  • Small Molecule Peptides

Segment by Grade

  • Feed Grade
  • Food Grade

Segment by Application

  • Personal Care Products
  • Cosmetic
  • Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Hydrolyzed Yeast Extract market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Personal Care Products, Cosmetic, Other evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Hydrolyzed Yeast Extract Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 5.4%
Regional growth momentum
Market share by segment
Key metrics
Base value
$1.18B
2025
Forecast
$1.7B
2032
CAGR
5.4%
2025–2032
Regiões
5
global
Key companies
Angel Yeast(CN)Sinochem Nanjing(CN)Tangshan Top Bio_Technology(CN)Ichimaru Pharcos(JP)Thermo Fisher Scientific(US)MP Biomedicals(US)FUJIFILM Irvine Scientific(US)Organotechnie(FR)
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Degree of Protein Hydrolysis: <20%Moderately Hydrolyzed: 20%–50%Extensively Hydrolyzed: ≥50%–80%
By Application
Personal Care ProductsCosmeticOther

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Degree of Protein Hydrolysis: <20%
  • 3.1.3 Moderately Hydrolyzed: 20%–50%
  • 3.1.4 Extensively Hydrolyzed: ≥50%–80%
  • 3.1.5 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Personal Care Products
  • 4.1.3 Cosmetic
  • 4.1.4 Other
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Angel Yeast(CN)
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Sinochem Nanjing(CN)
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Tangshan Top Bio_Technology(CN)
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Ichimaru Pharcos(JP)
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Thermo Fisher Scientific(US)
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 MP Biomedicals(US)
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 FUJIFILM Irvine Scientific(US)
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Organotechnie(FR)
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Solabia Group (FR)
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Ohly GmbH (DE)
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Lallemand Animal Nutrition (CA)
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Leiber GmbH (DE)
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Biorigin (BR)
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 The Lubrizol Corporation(US)
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Croda International(GB)
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 BASF(DE)
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Barnet Products LLC (US)
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Naturalis Srl (IT)
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
  • 8.19 Carrubba Incorporated (US)
  • 8.19.1 Company Overview
  • 8.19.2 Key Products & Segments
  • 8.19.3 Financial Performance (2023–2025)
  • 8.19.4 Business Strategy
  • 8.19.5 SWOT Analysis
  • 8.19.6 Strategic Implications (2026–2032)
  • 8.20 Ashland (US)
  • 8.20.1 Company Overview
  • 8.20.2 Key Products & Segments
  • 8.20.3 Financial Performance (2023–2025)
  • 8.20.4 Business Strategy
  • 8.20.5 SWOT Analysis
  • 8.20.6 Strategic Implications (2026–2032)
  • 8.21 Sensient Technologies Corporation (US)
  • 8.21.1 Company Overview
  • 8.21.2 Key Products & Segments
  • 8.21.3 Financial Performance (2023–2025)
  • 8.21.4 Business Strategy
  • 8.21.5 SWOT Analysis
  • 8.21.6 Strategic Implications (2026–2032)
  • 8.22 Biogründl, S.L. (ES)
  • 8.22.1 Company Overview
  • 8.22.2 Key Products & Segments
  • 8.22.3 Financial Performance (2023–2025)
  • 8.22.4 Business Strategy
  • 8.22.5 SWOT Analysis
  • 8.22.6 Strategic Implications (2026–2032)
  • 8.23 BOC Sciences (US)
  • 8.23.1 Company Overview
  • 8.23.2 Key Products & Segments
  • 8.23.3 Financial Performance (2023–2025)
  • 8.23.4 Business Strategy
  • 8.23.5 SWOT Analysis
  • 8.23.6 Strategic Implications (2026–2032)
  • 8.24 Cobiosa (ES)
  • 8.24.1 Company Overview
  • 8.24.2 Key Products & Segments
  • 8.24.3 Financial Performance (2023–2025)
  • 8.24.4 Business Strategy
  • 8.24.5 SWOT Analysis
  • 8.24.6 Strategic Implications (2026–2032)
  • 8.25 Biocogent LLC (US)
  • 8.25.1 Company Overview
  • 8.25.2 Key Products & Segments
  • 8.25.3 Financial Performance (2023–2025)
  • 8.25.4 Business Strategy
  • 8.25.5 SWOT Analysis
  • 8.25.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global Hydrolyzed Yeast Extract market?
The global Hydrolyzed Yeast Extract market is estimated at US$ 1.18 billion in 2025 (base year) and is projected to reach US$ 1.7 billion by 2032.
What is the forecast CAGR for the Hydrolyzed Yeast Extract market?
The market is expected to grow at a CAGR of 5.4% from 2026 to 2032, expanding from US$ 1.18 billion in 2025 to US$ 1.7 billion in 2032, roughly 1.4 times its base-year value.
What is Hydrolyzed Yeast Extract?
Hydrolyzed yeast extract refers to a mixture of natural active ingredients obtained by using yeast cells (such as Saccharomyces cerevisiae) as raw materials. The cell walls are broken down and intracellular components are released through enzymatic hydrolysis or autolysis. The extract is then separated, concentrated, and dried.
How is the Hydrolyzed Yeast Extract market segmented by type?
By type, the market is segmented into Degree of Protein Hydrolysis: <20%, Moderately Hydrolyzed: 20%–50% and Extensively Hydrolyzed: ≥50%–80%.
What are the key applications of Hydrolyzed Yeast Extract?
Key applications covered include Personal Care Products, Cosmetic and Other.
Which companies are profiled in the Hydrolyzed Yeast Extract market report?
Key players profiled include Angel Yeast(CN), Sinochem Nanjing(CN), Tangshan Top Bio_Technology(CN), Ichimaru Pharcos(JP), Thermo Fisher Scientific(US), MP Biomedicals(US), FUJIFILM Irvine Scientific(US) and Organotechnie(FR), among 25 companies covered in total.
What geographies does the Hydrolyzed Yeast Extract market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Hydrolyzed Yeast Extract?
Overall, the industry structure presents a pattern of "fermentation raw material-driven growth + midstream process value-added growth + downstream application premium."
What are the main risks and barriers in the Hydrolyzed Yeast Extract market?
Midstream hydrolysis and extraction processing has certain technological and formulation barriers (such as nucleotide control and flavor-oriented development), with gross profit margins generally ranging from 25% to 50%.
Who should buy the Hydrolyzed Yeast Extract market report?
The report is intended for manufacturers and solution providers, distributors and end users in Personal Care Products, Cosmetic and Other, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Hydrolyzed Yeast Extract market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from US$ 3.500,00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.